Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients

Warfarin Pharmacogenomics in Diverse Populations

(2017) Justin B. Kaye et al.   PHARMACOTHERAPY

An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance

(2016) Payman Shahabi et al.   THROMBOSIS AND HAEMOSTASIS

Exact Parametric Confidence Intervals for Bland-Altman Limits of Agreement

(2015) Andrew Carkeet   OPTOMETRY AND VISION SCIENCE

A Randomized Trial of Genotype-Guided Dosing of Warfarin

(2013) Munir Pirmohamed et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect ofNQO1andCYP4F2genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans

(2012) Adam Bress et al.   PHARMACOGENOMICS

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

(2010) P.-C. Cha et al.   HUMAN MOLECULAR GENETICS

VKORC1,CYP2C9andCYP4F2genetic-based algorithm for warfarin dosing: an Italian retrospective study

(2010) Carlo-Federico Zambon et al.   PHARMACOGENOMICS

Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients

(2009) Masako Ohno et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant

(2009) M. G. McDonald et al.   MOLECULAR PHARMACOLOGY

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients

(2009) Sheng-Wen Huang et al.   Pharmacogenetics and Genomics

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

(2009) Rianne MF van Schie et al.   PHARMACOGENOMICS

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Critical Path of Warfarin Dosing: Finding an Optimal Dosing Strategy Using Pharmacogenetics

(2008) LJ Lesko   CLINICAL PHARMACOLOGY & THERAPEUTICS

Warfarin Pharmacogenetics

(2008) Nita A Limdi et al.   PHARMACOTHERAPY

Warfarin: An Old Drug but Still Interesting

(2008) Julie A Johnson   PHARMACOTHERAPY